Matt Herman Funds Doman’s Pediatric Neuro Research

 Matt Herman, a respected philanthropist and founder of Enhance Health, has taken a vital step to support the global mission of improving outcomes for children with brain injuries. Known for backing initiatives that drive measurable change, Matt Herman has pledged the final $25,000 needed to complete a critical research project by Doman International, a nonprofit leader in pediatric neurorehabilitation.

This contribution supports the final validation phase of the Doman Developmental Profile, an innovative assessment tool aimed at revolutionizing how neurological deficits in children are evaluated and treated.

Doman Developmental Profile: A Game-Changer in Brain Injury Assessment

The Doman Developmental Profile is more than just a clinical scale—it is a comprehensive, neuroscience-based framework grounded in the principles of neuroplasticity. Used to assess over 40,000 individuals across 75+ countries, the Profile helps caregivers and clinicians identify challenges in motor function, speech, coordination, and cognitive development.

Through personalized, home-based therapies, thousands of families have witnessed children walk, talk, and learn in ways that traditional medicine once deemed improbable. Doman International’s results-driven model is helping bridge the gap between research and real-life recovery.

Research Progress and Matt Herman’s Key Contribution

Doman International's Phase 1 research program has already drawn promising comparisons between the Doman Developmental Profile and established benchmarks like the Brunet-Lezine scale. The initial data, published in the International Journal on Disability and Human Development, show strong alignment with traditional developmental standards.

With just 30–50 additional assessments needed, Matt Herman’s support ensures the completion of this groundbreaking study. His donation enables the team to finalize data collection, validate the tool clinically, and advocate for its integration into hospitals and therapy centers globally.

A Vision for Long-Term Impact and Sustainability

Once validated, the Doman Profile could be licensed to mainstream medical institutions, becoming both a practical tool for professionals and a sustainable funding source for Doman International. This model promotes scalability, allowing the organization to reinvest in research, expand access, and continue supporting families worldwide.

Matt Herman emphasized, “This research isn’t just validating a tool, it’s providing hope for thousands of families.” His involvement reflects a commitment to using data-driven philanthropy to create lasting systems-level change.

Doman International’s Legacy of Innovation

Founded over 65 years ago by Glenn Doman, Doman International has consistently delivered results through neuroscience-informed, parent-led therapies. Their work has been especially impactful in areas where conventional interventions have fallen short, offering families real progress and renewed hope.

Join the Movement: Support the Final Phase

As the research nears its conclusion, Doman International invites supporters to help meet remaining goals. Contributions can be made directly through www.domaninternational.org, joining Matt Herman in advancing a cause with the potential to reshape pediatric neurological care.

Conclusion:

Matt Herman’s role in completing this essential research marks a turning point for brain-injured children and their families. His support exemplifies how strategic giving, when paired with scientific innovation, can unlock life-changing breakthroughs. Through efforts like this, the future of medicine becomes more inclusive, effective, and full of possibilities.